世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および米国の好酸球性喘息治療薬の市場規模、現状および見通し 2021-2027年


Global and United States Eosinophilic Asthma Treatment Market Size, Status and Forecast 2021-2027

市場分析と洞察。好酸球性喘息治療薬の世界市場 当レポートでは、世界および米国の好酸球性喘息治療薬市場に焦点を当てています。 2020年の好酸球性喘息治療の世界市場規模は9901百万米ドルで、2021-2027年の間... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2022年1月22日 US$3,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

市場分析と洞察。好酸球性喘息治療薬の世界市場
当レポートでは、世界および米国の好酸球性喘息治療薬市場に焦点を当てています。
2020年の好酸球性喘息治療の世界市場規模は9901百万米ドルで、2021-2027年の間に38.99%のCAGRで、2027年末には98355百万米ドルに達すると予想されています。米国では、好酸球性喘息治療薬の市場規模は、2020年の3590百万米ドルから2027年には38112百万米ドルまで、予測期間中に40.24%のCAGRで成長すると予測されています。
世界の好酸球性喘息治療薬のスコープと市場規模
好酸球性喘息治療薬市場は、プレイヤー別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界のEosinophilic Asthma Treatment市場のプレーヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間で、タイプ別とアプリケーション別の収益と予測に焦点を当てています。
企業別
ジェネンテック（ロシュ・グループ）&ノバルティス
Regeneron Pharmaceuticals&Sanofi
ジーエスケー
アストラゼネカ
テバ社

タイプ別セグメント
点滴静注
皮下注射

用途別セグメント
子供
ティーンエイジャー
大人

地域別
北アメリカ
アメリカ
カナダ

アジア太平洋
日本
インド
東南アジア
オーストラリア
その他

ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧

ラテンアメリカ
メキシコ
ブラジル

中近東・アフリカ
中近東
アフリカ


ページTOPに戻る


目次

1 REPORT OVERVIEW 1
1.1 Study Scope 1
1.2 Market Analysis by Type 1
1.2.1 Global Eosinophilic Asthma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1
1.2.2 Intravenous Infusion 2
1.2.3 Subcutaneous Injection 3
1.3 Market by Application 3
1.3.1 Global Eosinophilic Asthma Treatment Market Share by Application: 2016 VS 2021 VS 2027 4
1.3.2 Children 5
1.3.3 Teenagers 5
1.3.4 Adults 5
1.4 Study Objectives 6
1.5 Years Considered 7
2 GLOBAL GROWTH TRENDS 8
2.1 Global Eosinophilic Asthma Treatment Market Perspective (2016-2027) 8
2.2 Eosinophilic Asthma Treatment Growth Trends by Regions 9
2.2.1 Eosinophilic Asthma Treatment Market Size by Regions: 2016 VS 2021 VS 2027 9
2.2.2 Eosinophilic Asthma Treatment Historic Market Size by Regions (2016-2021) 10
2.2.3 Eosinophilic Asthma Treatment Forecasted Market Size by Regions (2022-2027) 11
2.2.4 United States Eosinophilic Asthma Treatment Market Share in Global Market 2016-2027 12
2.3 Eosinophilic Asthma Treatment Industry Dynamic 13
2.3.1 Eosinophilic Asthma Treatment Market Trends 13
2.3.2 Eosinophilic Asthma Treatment Market Drivers 13
2.3.3 Eosinophilic Asthma Treatment Market Challenges 13
2.3.4 Eosinophilic Asthma Treatment Market Restraints 14
3 THE NUMBER OF PATIENTS OF EOSINOPHILIC ASTHMA BY REGIONS 15
3.1 The Number of Patients of Eosinophilic Asthma by Regions (2019-2021) 15
3.2 The Prevalence Rate of Eosinophilic Asthma by Regions (2019-2021) 15
4 COMPETITION LANDSCAPE BY KEY PLAYERS 16
4.1 Global Top Eosinophilic Asthma Treatment Players by Revenue 16
4.1.1 Global Top Eosinophilic Asthma Treatment Players by Revenue (2016-2021) 16
4.1.2 Global Eosinophilic Asthma Treatment Revenue Market Share by Players (2016-2021) 16
4.2 Global Eosinophilic Asthma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 17
4.3 Players Covered: Ranking by Eosinophilic Asthma Treatment Revenue 18
4.4 Global Eosinophilic Asthma Treatment Market Concentration Ratio 18
4.4.1 Global Eosinophilic Asthma Treatment Market Concentration Ratio (CR3 and HHI) 18
4.4.2 Global Top 3 Companies by Eosinophilic Asthma Treatment Revenue in 2020 19
4.5 Eosinophilic Asthma Treatment Key Players Head office 20
4.6 Key Players Eosinophilic Asthma Treatment Product Solution and Service 20
4.7 Date of Enter into Eosinophilic Asthma Treatment Market 20
4.8 Mergers & Acquisitions, Expansion Plans 21
5 EOSINOPHILIC ASTHMA TREATMENT BREAKDOWN DATA BY TYPE 22
5.1 Global Eosinophilic Asthma Treatment Historic Market Size by Type (2016-2021) 22
5.2 Global Eosinophilic Asthma Treatment Forecasted Market Size by Type (2022-2027) 23
6 EOSINOPHILIC ASTHMA TREATMENT BREAKDOWN DATA BY APPLICATION 24
6.1 Global Eosinophilic Asthma Treatment Historic Market Size by Application (2016-2021) 24
6.2 Global Eosinophilic Asthma Treatment Forecasted Market Size by Application (2022-2027) 25
7 NORTH AMERICA 26
7.1 North America Eosinophilic Asthma Treatment Market Size (2016-2027) 26
7.2 North America Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 26
7.3 North America Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 27
7.4 North America Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 27
7.4.1 United States 28
7.4.2 Canada 29
8 EUROPE 30
8.1 Europe Eosinophilic Asthma Treatment Market Size (2016-2027) 30
8.2 Europe Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 30
8.3 Europe Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 31
8.4 Europe Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 31
8.4.1 Germany 32
8.4.2 France 33
8.4.3 U.K. 33
8.4.4 Italy 34
8.4.5 Russia 34
8.4.6 Spain 35
9 ASIA-PACIFIC 36
9.1 Asia-Pacific Eosinophilic Asthma Treatment Market Size (2016-2027) 36
9.2 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 36
9.3 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 37
9.4 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 37
9.4.1 Japan 38
9.4.2 India 39
9.4.3 Southeast Asia 39
9.4.4 Australia 40
10 LATIN AMERICA 41
10.1 Latin America Eosinophilic Asthma Treatment Market Size (2016-2027) 41
10.2 Latin America Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 41
10.3 Latin America Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 42
10.4 Latin America Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 42
10.4.1 Mexico 43
10.4.2 Brazil 44
11 MIDDLE EAST & AFRICA 45
11.1 Middle East & Africa Eosinophilic Asthma Treatment Market Size (2016-2027) 45
11.2 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 45
11.3 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 46
11.4 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 47
11.4.1 Middle East 47
11.4.2 Africa 48
12 KEY PLAYERS PROFILES 49
12.1 Genentech(Roche Group)&Novartis 49
12.1.1 Genentech(Roche Group) Company Details 49
12.1.2 Genentech(Roche Group) Business Overview 49
12.1.3 Novartis Company Details 50
12.1.4 Novartis Business Overview 50
Sandoz Department 50
12.1.5 Genentech(Roche Group)&Novartis Eosinophilic Asthma Treatment Introduction 51
12.1.6 Genentech(Roche Group)&Novartis Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 51
12.2 Regeneron Pharmaceuticals&Sanofi 52
12.2.1 Regeneron Pharmaceuticals Company Details 52
12.2.2 Regeneron Pharmaceuticals Business Overview 53
12.2.3 Sanofi Company Details 53
12.2.4 Sanofi Business Overview 53
12.2.5 Regeneron Pharmaceuticals&Sanofi Eosinophilic Asthma Treatment Introduction 54
12.2.6 Regeneron Pharmaceuticals&Sanofi Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 54
12.3 GlaxoSmithKline 55
12.3.1 GlaxoSmithKline Company Details 55
12.3.2 GlaxoSmithKline Business Overview 56
12.3.3 GlaxoSmithKline Eosinophilic Asthma Treatment Introduction 56
12.3.4 GlaxoSmithKline Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 57
12.4 AstraZeneca 57
12.4.1 AstraZeneca Company Details 57
12.4.2 AstraZeneca Business Overview 58
12.4.3 AstraZeneca Eosinophilic Asthma Treatment Introduction 58
12.4.4 AstraZeneca Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 59
12.5 Teva Pharmaceutical Industries Ltd. 60
12.5.1 Teva Pharmaceutical Industries Ltd. Company Details 60
12.5.2 Teva Pharmaceutical Industries Ltd. Business Overview 60
12.5.3 Teva Pharmaceutical Industries Ltd. Eosinophilic Asthma Treatment Introduction 60
12.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 61
13 ANALYST'S VIEWPOINTS/CONCLUSIONS 63
14 APPENDIX 64
14.1 Research Methodology 64
14.1.1 Methodology/Research Approach 64
14.1.2 Data Source 67
14.2 Disclaimer 70
14.3 Author Details 70

　

ページTOPに戻る


　

Summary

Market Analysis and Insights: Global Eosinophilic Asthma Treatment Market
This report focuses on global and United States Eosinophilic Asthma Treatment market.
In 2020, the global Eosinophilic Asthma Treatment market size was US$ 9901 million and it is expected to reach US$ 98355 million by the end of 2027, with a CAGR of 38.99% during 2021-2027. In United States the Eosinophilic Asthma Treatment market size is expected to grow from US$ 3590 million in 2020 to US$ 38112 million by 2027, at a CAGR of 40.24% during the forecast period.
Global Eosinophilic Asthma Treatment Scope and Market Size
Eosinophilic Asthma Treatment market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Eosinophilic Asthma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
By Company
Genentech(Roche Group)&Novartis
Regeneron Pharmaceuticals&Sanofi
Gsk
AstraZeneca
Teva Pharmaceutical

Segment by Type
Intravenous Infusion
Subcutaneous Injection

Segment by Application
Children
Teenagers
Adults

By Region
North America
United States
Canada

Asia-Pacific
Japan
India
Southeast Asia
Australia
Others

Europe
Germany
France
U.K.
Italy
Russia
Nordic

Latin America
Mexico
Brazil

Middle East & Africa
Middle East
Africa



ページTOPに戻る


Table of Contents

1 REPORT OVERVIEW 1
1.1 Study Scope 1
1.2 Market Analysis by Type 1
1.2.1 Global Eosinophilic Asthma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1
1.2.2 Intravenous Infusion 2
1.2.3 Subcutaneous Injection 3
1.3 Market by Application 3
1.3.1 Global Eosinophilic Asthma Treatment Market Share by Application: 2016 VS 2021 VS 2027 4
1.3.2 Children 5
1.3.3 Teenagers 5
1.3.4 Adults 5
1.4 Study Objectives 6
1.5 Years Considered 7
2 GLOBAL GROWTH TRENDS 8
2.1 Global Eosinophilic Asthma Treatment Market Perspective (2016-2027) 8
2.2 Eosinophilic Asthma Treatment Growth Trends by Regions 9
2.2.1 Eosinophilic Asthma Treatment Market Size by Regions: 2016 VS 2021 VS 2027 9
2.2.2 Eosinophilic Asthma Treatment Historic Market Size by Regions (2016-2021) 10
2.2.3 Eosinophilic Asthma Treatment Forecasted Market Size by Regions (2022-2027) 11
2.2.4 United States Eosinophilic Asthma Treatment Market Share in Global Market 2016-2027 12
2.3 Eosinophilic Asthma Treatment Industry Dynamic 13
2.3.1 Eosinophilic Asthma Treatment Market Trends 13
2.3.2 Eosinophilic Asthma Treatment Market Drivers 13
2.3.3 Eosinophilic Asthma Treatment Market Challenges 13
2.3.4 Eosinophilic Asthma Treatment Market Restraints 14
3 THE NUMBER OF PATIENTS OF EOSINOPHILIC ASTHMA BY REGIONS 15
3.1 The Number of Patients of Eosinophilic Asthma by Regions (2019-2021) 15
3.2 The Prevalence Rate of Eosinophilic Asthma by Regions (2019-2021) 15
4 COMPETITION LANDSCAPE BY KEY PLAYERS 16
4.1 Global Top Eosinophilic Asthma Treatment Players by Revenue 16
4.1.1 Global Top Eosinophilic Asthma Treatment Players by Revenue (2016-2021) 16
4.1.2 Global Eosinophilic Asthma Treatment Revenue Market Share by Players (2016-2021) 16
4.2 Global Eosinophilic Asthma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 17
4.3 Players Covered: Ranking by Eosinophilic Asthma Treatment Revenue 18
4.4 Global Eosinophilic Asthma Treatment Market Concentration Ratio 18
4.4.1 Global Eosinophilic Asthma Treatment Market Concentration Ratio (CR3 and HHI) 18
4.4.2 Global Top 3 Companies by Eosinophilic Asthma Treatment Revenue in 2020 19
4.5 Eosinophilic Asthma Treatment Key Players Head office 20
4.6 Key Players Eosinophilic Asthma Treatment Product Solution and Service 20
4.7 Date of Enter into Eosinophilic Asthma Treatment Market 20
4.8 Mergers & Acquisitions, Expansion Plans 21
5 EOSINOPHILIC ASTHMA TREATMENT BREAKDOWN DATA BY TYPE 22
5.1 Global Eosinophilic Asthma Treatment Historic Market Size by Type (2016-2021) 22
5.2 Global Eosinophilic Asthma Treatment Forecasted Market Size by Type (2022-2027) 23
6 EOSINOPHILIC ASTHMA TREATMENT BREAKDOWN DATA BY APPLICATION 24
6.1 Global Eosinophilic Asthma Treatment Historic Market Size by Application (2016-2021) 24
6.2 Global Eosinophilic Asthma Treatment Forecasted Market Size by Application (2022-2027) 25
7 NORTH AMERICA 26
7.1 North America Eosinophilic Asthma Treatment Market Size (2016-2027) 26
7.2 North America Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 26
7.3 North America Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 27
7.4 North America Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 27
7.4.1 United States 28
7.4.2 Canada 29
8 EUROPE 30
8.1 Europe Eosinophilic Asthma Treatment Market Size (2016-2027) 30
8.2 Europe Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 30
8.3 Europe Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 31
8.4 Europe Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 31
8.4.1 Germany 32
8.4.2 France 33
8.4.3 U.K. 33
8.4.4 Italy 34
8.4.5 Russia 34
8.4.6 Spain 35
9 ASIA-PACIFIC 36
9.1 Asia-Pacific Eosinophilic Asthma Treatment Market Size (2016-2027) 36
9.2 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 36
9.3 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 37
9.4 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 37
9.4.1 Japan 38
9.4.2 India 39
9.4.3 Southeast Asia 39
9.4.4 Australia 40
10 LATIN AMERICA 41
10.1 Latin America Eosinophilic Asthma Treatment Market Size (2016-2027) 41
10.2 Latin America Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 41
10.3 Latin America Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 42
10.4 Latin America Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 42
10.4.1 Mexico 43
10.4.2 Brazil 44
11 MIDDLE EAST & AFRICA 45
11.1 Middle East & Africa Eosinophilic Asthma Treatment Market Size (2016-2027) 45
11.2 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Type (2016-2021) 45
11.3 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Application (2016-2021) 46
11.4 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Country (2016-2021) 47
11.4.1 Middle East 47
11.4.2 Africa 48
12 KEY PLAYERS PROFILES 49
12.1 Genentech(Roche Group)&Novartis 49
12.1.1 Genentech(Roche Group) Company Details 49
12.1.2 Genentech(Roche Group) Business Overview 49
12.1.3 Novartis Company Details 50
12.1.4 Novartis Business Overview 50
Sandoz Department 50
12.1.5 Genentech(Roche Group)&Novartis Eosinophilic Asthma Treatment Introduction 51
12.1.6 Genentech(Roche Group)&Novartis Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 51
12.2 Regeneron Pharmaceuticals&Sanofi 52
12.2.1 Regeneron Pharmaceuticals Company Details 52
12.2.2 Regeneron Pharmaceuticals Business Overview 53
12.2.3 Sanofi Company Details 53
12.2.4 Sanofi Business Overview 53
12.2.5 Regeneron Pharmaceuticals&Sanofi Eosinophilic Asthma Treatment Introduction 54
12.2.6 Regeneron Pharmaceuticals&Sanofi Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 54
12.3 GlaxoSmithKline 55
12.3.1 GlaxoSmithKline Company Details 55
12.3.2 GlaxoSmithKline Business Overview 56
12.3.3 GlaxoSmithKline Eosinophilic Asthma Treatment Introduction 56
12.3.4 GlaxoSmithKline Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 57
12.4 AstraZeneca 57
12.4.1 AstraZeneca Company Details 57
12.4.2 AstraZeneca Business Overview 58
12.4.3 AstraZeneca Eosinophilic Asthma Treatment Introduction 58
12.4.4 AstraZeneca Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 59
12.5 Teva Pharmaceutical Industries Ltd. 60
12.5.1 Teva Pharmaceutical Industries Ltd. Company Details 60
12.5.2 Teva Pharmaceutical Industries Ltd. Business Overview 60
12.5.3 Teva Pharmaceutical Industries Ltd. Eosinophilic Asthma Treatment Introduction 60
12.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Eosinophilic Asthma Treatment Business (2016-2021) 61
13 ANALYST'S VIEWPOINTS/CONCLUSIONS 63
14 APPENDIX 64
14.1 Research Methodology 64
14.1.1 Methodology/Research Approach 64
14.1.2 Data Source 67
14.2 Disclaimer 70
14.3 Author Details 70

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（アレルギー用薬）の最新刊レポート

QYResearch社のアレルギー用薬分野での最新刊レポート

本レポートと同じKEY WORD（asthma）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20　10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.